Multi-symptom Pms Relief Tablet, Film Coated
NDC Package 51316-679-27

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Multi-symptom Pms Relief (acetaminophen, pamabrom, pyrilamine maleate) tablets is do not take more than directedadults and children 12 years and over:take 2 caplets with water every 6 hours as neededdo not exceed 6 caplets in a 24 hour period or as directed by a doctorchildren under 12 years: ask a doctor. This formulation utilizes a tablet, film coated delivery system. Marketed by Cvs Woonsocket Prescription Center, Incorporated, this product is identified by NDC 51316-679 and is authorized under FDA application M013.

Identification & Billing

NDC Package Code
51316-679-27
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 32 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Product Code
51316-679
11-Digit Billing Format
51316067927
RxNorm Crosswalk
  • RxCUI: 1052637 - acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet
  • RxCUI: 1052637 - APAP 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet

Clinical Specifications

Proprietary Name
Multi-symptom Pms Relief
Non-Proprietary Name
Acetaminophen, Pamabrom, Pyrilamine Maleate
Substance Name
Acetaminophen; Pamabrom; Pyrilamine Maleate
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Do not take more than directedadults and children 12 years and over:take 2 caplets with water every 6 hours as neededdo not exceed 6 caplets in a 24 hour period or as directed by a doctorchildren under 12 years: ask a doctor

Regulatory & Marketing

Labeler Name
Cvs Woonsocket Prescription Center, Incorporated
Product Type
Human Otc Drug
FDA Application #
M013
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-03-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51316-679-27 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 32 tablet, film coated in 1 bottle, plastic of Multi-symptom Pms Relief, a human over the counter drug labeled by Cvs Woonsocket Prescription Center, Incorporated. This tablet, film coated is formulated for oral use and contains acetaminophen; pamabrom; pyrilamine maleate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cvs Woonsocket Prescription Center, Incorporated on June 03, 2026. The current certification is valid through December 31, 2027.

How is this Cvs Woonsocket Prescription Center, Incorporated product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51316067927. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51316-679-27
11-Digit CMS (5-4-2)
51316-0679-27

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.